UK markets close in 7 hours 35 minutes

NVO Nov 2022 110.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.75000.0000 (0.00%)
As of 11:17AM EDT. Market open.
Full screen
Previous close1.7500
Open1.7500
Bid0.0000
Ask0.0000
Strike110.00
Expiry date2022-11-18
Day's range1.7000 - 1.7500
Contract rangeN/A
Volume59
Open interestN/A
  • Zacks

    Top Analyst Reports for Novo Nordisk, Suncor Energy, & Nasdaq

    Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S (NVO), Suncor Energy Inc. (SU) and Nasdaq, Inc. (NDAQ).

  • Motley Fool

    This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

    Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?

  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 26 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme